-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Tvx4akBe/brISU1KfQ6iWJOOyxoCMbYhi4UOvW6eS0tinZEGA2di6Gk58r5M/xbR V/bwcFGKUrarYHNAj+BbZA== 0000911420-05-000378.txt : 20050914 0000911420-05-000378.hdr.sgml : 20050914 20050914142724 ACCESSION NUMBER: 0000911420-05-000378 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050731 FILED AS OF DATE: 20050914 DATE AS OF CHANGE: 20050914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THALENFELD BARBARA E CENTRAL INDEX KEY: 0001236358 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 051084175 BUSINESS ADDRESS: STREET 1: C/O ENZO BIOCHEM INC STREET 2: 527 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2125830100 MAIL ADDRESS: STREET 1: 527 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 5 1 p1112245_ex.xml X0202 5 2005-07-31 0 0 0 0000316253 ENZO BIOCHEM INC ENZ 0001236358 THALENFELD BARBARA E C/O ENZO BIOCHEM INC 527 MADISON AVE NEW YORK NY 10022 0 1 0 0 Vice President, Corporate Devl Common Stock, par value $0.01 per share 2004-12-10 5 M 0 7036 7.107 A 14817 D Common Stock, par value $0.01 per share 2005-02-05 5 S 0 2697 18.51 D 14817 D Common Stock, par value $0.01 per share 2005-07-11 5 S 0 3570 17.80 D 14817 D Employee Stock Option 7.107 2004-12-10 5 M 0 7036 0 D 1998-12-20 2004-12-20 Common Stock, par value $0.01 per share 7036 41905 D As of the end of Issuer's Fiscal Year, 07/31/2005, the Reporting Person directly beneficially owned 14,817 shares of Common Stock, 381 shares of Common Stock in Enzo Biochem's 401(K) Plan, and 41,905 options to purchase Common Stock, par value $0.01 per share, exercisable. /s/ Barbara E. Thalenfeld 2005-09-14 -----END PRIVACY-ENHANCED MESSAGE-----